Felix Frueh

Felix Frueh has had a varied career since 2012. Felix began as Founder and Executive Partner at Opus Three LLC in 2012, and also served as Director and Secretary at CredibleMeds powered by AZCERT.org. In 2016, they took on roles as Scientific Advisor at Merck KGaA, Darmstadt, Germany, and Co-Founder and Chief Executive Officer at Intellos Health LLC. In 2017, they became Co-Founder and CSO at Selva Therapeutics, Inc. Felix has also served as Director at Ariana Pharma (2016) and Bloom Science, Inc. (2018), and as Advisor at TriAxia Health, Inc. (2019). Most recently, in 2022, they became Director at GENinCode_ Predictive Genetics.

Felix Frueh obtained their PhD in Biochemistry and Molecular Biology from the University of Basel between 1989 and 1995. Felix then went on to become a Research Fellow in Molecular Pharmacology at Stanford University from 1996 to 1999.